BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
Number Citing Articles
1 Ingram DG, Jesteadt L, Crisp C, Simon SL. Perceived challenges in pediatric narcolepsy: a survey of parents, youth, and sleep physicians. J Clin Sleep Med 2021;17:13-22. [PMID: 32895119 DOI: 10.5664/jcsm.8774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Immunotherapy in Narcolepsy. Curr Treat Options Neurol 2020;22:2. [PMID: 31997035 DOI: 10.1007/s11940-020-0609-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim HC, Lee DA, Lee HJ, Shin KJ, Park KM. Alterations in the structural covariance network of the hypothalamus in patients with narcolepsy. Neuroradiology 2022. [PMID: 35013760 DOI: 10.1007/s00234-021-02878-6] [Reference Citation Analysis]
4 Thieux M, Zhang M, Marcastel A, Herbillon V, Guignard-Perret A, Seugnet L, Lin JS, Guyon A, Plancoulaine S, Franco P. Intellectual Abilities of Children with Narcolepsy. J Clin Med 2020;9:E4075. [PMID: 33348677 DOI: 10.3390/jcm9124075] [Reference Citation Analysis]
5 Postiglione E, Pizza F, Ingravallo F, Vignatelli L, Filardi M, Mangiaruga A, Antelmi E, Moresco M, Oriolo C, Pagotto U, Plazzi G. Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management. Brain Behav 2021;11:e01955. [PMID: 33247632 DOI: 10.1002/brb3.1955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Dauvilliers Y, Barateau L, Lopez R, Rassu AL, Chenini S, Beziat S, Jaussent I. Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences. Sleep 2020;43:zsaa009. [DOI: 10.1093/sleep/zsaa009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
7 Ballotta D, Talami F, Pizza F, Vaudano AE, Benuzzi F, Plazzi G, Meletti S. Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1. Neuroimage Clin 2021;31:102748. [PMID: 34252875 DOI: 10.1016/j.nicl.2021.102748] [Reference Citation Analysis]
8 Ni K, Liu Y, Zhu X, Tan H, Zeng Y, Guo Q, Xiao L, Yu B. Changed Cerebral White Matter Structural Network Topological Characters and Its Correlation with Cognitive Behavioral Abnormalities in Narcolepsy Type 1. NSS 2022;Volume 14:165-73. [DOI: 10.2147/nss.s336967] [Reference Citation Analysis]
9 Geng C, Yang Z, Xu P, Zhang H. Psychological status and serum uric acid levels in narcolepsy with type 1: A case-control study. J Clin Neurosci 2022;97:17-20. [PMID: 35033776 DOI: 10.1016/j.jocn.2022.01.002] [Reference Citation Analysis]
10 Manolis TA, Manolis AA, Apostolopoulos EJ, Melita H, Manolis AS. Cardiovascular Complications of Sleep Disorders: A Better Night's Sleep for a Healthier Heart / From Bench to Bedside. Curr Vasc Pharmacol 2021;19:210-32. [PMID: 32209044 DOI: 10.2174/1570161118666200325102411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Lammers GJ, Bassetti CL, Dolenc-groselj L, Jennum PJ, Kallweit U, Khatami R, Lecendreux M, Manconi M, Mayer G, Partinen M, Plazzi G, Reading PJ, Santamaria J, Sonka K, Dauvilliers Y. Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep Medicine Reviews 2020;52:101306. [DOI: 10.1016/j.smrv.2020.101306] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
12 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
13 Pimentel Filho LH, Frange C, Coelho FMS. Narcolepsy Severity Scale: experience of a Brazilian Sleep Center. Sleep 2020;43:zsaa113. [DOI: 10.1093/sleep/zsaa113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Um YH, Oh J, Kim SM, Kim TW, Seo HJ, Jeong JH, Hong SC. Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: a longitudinal retrospective study. Sleep Breath 2021. [PMID: 34820763 DOI: 10.1007/s11325-021-02525-7] [Reference Citation Analysis]
16 Peter-Derex L, Subtil F, Lemaitre G, Ricordeau F, Bastuji H, Bridoux A, Onen F, Onen SH. Observation and Interview-based Diurnal Sleepiness Inventory for measurement of sleepiness in patients referred for narcolepsy or idiopathic hypersomnia. J Clin Sleep Med 2020;16:1507-15. [PMID: 32406372 DOI: 10.5664/jcsm.8574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Fabara SP, Ortiz JF, Anas Sohail A, Hidalgo J, Altamimi A, Tama B, Patel UK. Efficacy of Pitolisant on the Treatment of Narcolepsy: A Systematic Review. Cureus 2021;13:e16095. [PMID: 34345566 DOI: 10.7759/cureus.16095] [Reference Citation Analysis]
18 Grunstein R, Han F. Twenty-five years of Respirology: Advances in sleep. Respirology 2020;25:41-2. [PMID: 31840888 DOI: 10.1111/resp.13741] [Reference Citation Analysis]
19 Bernard-Valnet R, Frieser D, Nguyen XH, Khajavi L, Quériault C, Arthaud S, Melzi S, Fusade-Boyer M, Masson F, Zytnicki M, Saoudi A, Dauvilliers Y, Peyron C, Bauer J, Liblau RS. Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy. Brain 2022:awab455. [PMID: 35552381 DOI: 10.1093/brain/awab455] [Reference Citation Analysis]
20 Malter M, Neuneier J, Triller A, Kallweit U. [Narcolepsy in adults: Definition, etiology and treatment]. Fortschr Neurol Psychiatr 2021;89:103-13. [PMID: 33339064 DOI: 10.1055/a-1244-2612] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wu M, Ren J, Li SX, Xue P, Su C, Zhou J. Management of narcolepsy during COVID-19: a challenge or an opportunity? Sleep 2021;44:zsaa273. [PMID: 33576420 DOI: 10.1093/sleep/zsaa273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hong C, Byrne NJ, Zamlynny B, Tummala S, Xiao L, Shipman JM, Partridge AT, Minnick C, Breslin MJ, Rudd MT, Stachel SJ, Rada VL, Kern JC, Armacost KA, Hollingsworth SA, O'Brien JA, Hall DL, McDonald TP, Strickland C, Brooun A, Soisson SM, Hollenstein K. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nat Commun 2021;12:815. [PMID: 33547286 DOI: 10.1038/s41467-021-21087-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
23 Orjatsalo M, Partinen E, Wallukat G, Alakuijala A, Partinen M. Activating autoantibodies against G protein-coupled receptors in narcolepsy type 1. Sleep Med 2021;77:82-7. [PMID: 33341642 DOI: 10.1016/j.sleep.2020.11.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pimentel Filho LH, Gomes ACD, Frange C, Tufik S, Coelho FMS. Validation of the Brazilian Portuguese version of the narcolepsy severity scale. Sleep Med 2020;76:134-9. [PMID: 33166827 DOI: 10.1016/j.sleep.2020.10.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Gill I, Sheils A, Reade E, O’malley S, Carey A, Muldoon M, Wagle A, Crowe C, Lynch B. Narcolepsy in children and young people in Ireland: 2006–2017. European Journal of Paediatric Neurology 2020;28:52-7. [DOI: 10.1016/j.ejpn.2020.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O'Malley S, Lynch B, Crowe C. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. [PMID: 33289477 DOI: 10.5664/jcsm.9052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Schmidt MH, Dekkers MPJ, Baillieul S, Jendoubi J, Wulf MA, Wenz E, Fregolente L, Vorster A, Gnarra O, Bassetti CLA. Measuring Sleep, Wakefulness, and Circadian Functions in Neurologic Disorders. Sleep Med Clin 2021;16:661-71. [PMID: 34711389 DOI: 10.1016/j.jsmc.2021.08.005] [Reference Citation Analysis]
28 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
29 Barateau L, Dauvilliers Y. Recent advances in treatment for narcolepsy. Ther Adv Neurol Disord 2019;12:1756286419875622. [PMID: 31632459 DOI: 10.1177/1756286419875622] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
30 Pellitteri G, de Biase S, Valente M, Gigli GL. How treatable is narcolepsy with current pharmacotherapy and what does the future hold? Expert Opin Pharmacother 2021;22:1517-20. [PMID: 33882765 DOI: 10.1080/14656566.2021.1915987] [Reference Citation Analysis]
31 Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollmächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res 2021;:e13387. [PMID: 34173288 DOI: 10.1111/jsr.13387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ando T, Wakai M, Kanbayashi T, Katsuno M. Status Cataplecticus with Rapid Eye Movement Sleep Excess in Late-onset Narcolepsy Type 1. Intern Med . [DOI: 10.2169/internalmedicine.8465-21] [Reference Citation Analysis]
33 Akyildiz UO, Tezer FI, Koc G, Ismailogullari S, Demir AB, Ak AK, Sunter G, Kara KA, Berktas DT, Sahin A, Azman F, Akcay BD, Gok DK, Yilmaz H, Agan K, Bekmezci Y, Yetkin S, Aksu M, Karadeniz D, Senel GB. The REM-sleep related characteristics of narcolepsy: A nation-wide multi-center study in Turkey, the REMCON study. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.03.025] [Reference Citation Analysis]
34 Ferini-Strambi L, Auer R, Bjorvatn B, Castronovo V, Franco O, Gabutti L, Galbiati A, Hajak G, Khatami R, Kitajima T, McEvoy D, Nissen C, Perlis M, Pevernagie DA, Randerath W, Riemann D, Rizzo G, Van Someren E, Vgontzas A, Barazzoni F, Bassetti C; European Sleep Foundation. Insomnia disorder: clinical and research challenges for the 21st century. Eur J Neurol 2021;28:2156-67. [PMID: 33619858 DOI: 10.1111/ene.14784] [Reference Citation Analysis]
35 Subedi R, Singh R, Thakur RK, K C B, Jha D, Ray BK. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials. Sleep Med 2020;75:510-21. [PMID: 33032062 DOI: 10.1016/j.sleep.2020.09.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Davis CW, Kallweit U, Schwartz JC, Krahn LE, Vaughn B, Thorpy MJ. Efficacy of pitolisant in patients with high burden of narcolepsy symptoms: pooled analysis of short-term, placebo-controlled studies. Sleep Med 2021;81:210-7. [PMID: 33721598 DOI: 10.1016/j.sleep.2021.02.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Melzi S, Morel AL, Scoté-Blachon C, Liblau R, Dauvilliers Y, Peyron C. Histamine in murine narcolepsy: What do genetic and immune models tell us? Brain Pathol 2021;:e13027. [PMID: 34672414 DOI: 10.1111/bpa.13027] [Reference Citation Analysis]
38 Stieglitz S, Heppner HJ, Netzer N. Abnormal things happening during sleep: parasomnias. Z Gerontol Geriatr 2020;53:119-22. [PMID: 32140765 DOI: 10.1007/s00391-020-01714-5] [Reference Citation Analysis]
39 Berro LF, Overton JS, Rowlett JK. Methamphetamine-Induced Sleep Impairments and Subsequent Slow-Wave and Rapid Eye Movement Sleep Rebound in Male Rhesus Monkeys. Front Neurosci 2022;16:866971. [DOI: 10.3389/fnins.2022.866971] [Reference Citation Analysis]
40 Kuts A, Poluektov M, Bassetti CLA. The evolution of the narcolepsy concept in Russia: A historical view. J Hist Neurosci 2021;30:113-27. [PMID: 32603636 DOI: 10.1080/0964704X.2020.1777502] [Reference Citation Analysis]
41 Peron A, Catusi I, Recalcati MP, Calzari L, Larizza L, Vignoli A, Canevini MP. Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and Overlapping Phenotypes. Front Neurol 2020;11:613035. [PMID: 33363513 DOI: 10.3389/fneur.2020.613035] [Reference Citation Analysis]
42 DelRosso LM, Mogavero MP, Ferri R, Bruni O, Chen ML. Update and Progress in Pediatric Sleep Disorders. J Pediatr 2021:S0022-3476(21)00791-5. [PMID: 34450124 DOI: 10.1016/j.jpeds.2021.08.030] [Reference Citation Analysis]
43 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
44 Amadei E, Cantile C, Gazzano A, Pierantoni L, Mariti C. The link between neurology and behavior in veterinary medicine: A review. Journal of Veterinary Behavior 2021;46:40-53. [DOI: 10.1016/j.jveb.2021.07.003] [Reference Citation Analysis]
45 Zhang R, Gao S, Wang S, Zhang J, Bai Y, He S, Zhao P, Zhang H. Gut Microbiota in Patients with Type 1 Narcolepsy. Nat Sci Sleep 2021;13:2007-18. [PMID: 34785965 DOI: 10.2147/NSS.S330022] [Reference Citation Analysis]
46 Sivam S, Chamula K, Swieca J, Frenkel S, Saini B. Narcolepsy management in Australia: time to wake up. Med J Aust 2021;215:62-63.e1. [PMID: 34145573 DOI: 10.5694/mja2.51150] [Reference Citation Analysis]
47 Wu M, Li SX, Xue P, Zhou J, Tang X. COVID-19 Vaccine Could Trigger the Relapse of Secondary Hypersomnia. Nat Sci Sleep 2021;13:2267-71. [PMID: 35002346 DOI: 10.2147/NSS.S345801] [Reference Citation Analysis]
48 Mondino A, Delucchi L, Moeser A, Cerdá-González S, Vanini G. Sleep Disorders in dogs: A Pathophysiological and Clinical Review. Top Companion Anim Med 2021;43:100516. [PMID: 33556640 DOI: 10.1016/j.tcam.2021.100516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S. Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. J Immunother Cancer 2020;8:e001164. [PMID: 33004543 DOI: 10.1136/jitc-2020-001164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Zhang Z, Gool JK, Fronczek R, Dauvilliers Y, Bassetti CLA, Mayer G, Plazzi G, Pizza F, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Del Rio-Villegas R, Heinzer R, Wierzbicka A, Young P, Högl B, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Lammers GJ, Khatami R. New 2013 incidence peak in childhood narcolepsy: more than vaccination? Sleep 2021;44:zsaa172. [PMID: 32909046 DOI: 10.1093/sleep/zsaa172] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gandhi KD, Mansukhani MP, Silber MH, Kolla BP. Excessive Daytime Sleepiness: A Clinical Review. Mayo Clin Proc 2021;96:1288-301. [PMID: 33840518 DOI: 10.1016/j.mayocp.2020.08.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Jalal B, Moruzzi L, Zangrandi A, Filardi M, Franceschini C, Pizza F, Plazzi G. Meditation-Relaxation (MR Therapy) for Sleep Paralysis: A Pilot Study in Patients With Narcolepsy. Front Neurol 2020;11:922. [PMID: 32903364 DOI: 10.3389/fneur.2020.00922] [Reference Citation Analysis]
53 Järvelä M, Raatikainen V, Kotila A, Kananen J, Korhonen V, Uddin LQ, Ansakorpi H, Kiviniemi V. Lag Analysis of Fast fMRI Reveals Delayed Information Flow Between the Default Mode and Other Networks in Narcolepsy. Cereb Cortex Commun 2020;1:tgaa073. [PMID: 34296133 DOI: 10.1093/texcom/tgaa073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Bracey EF, Burdakov D. Fast sensory representations in the lateral hypothalamus and their roles in brain function. Physiology & Behavior 2020;222:112952. [DOI: 10.1016/j.physbeh.2020.112952] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Seifinejad A, Li S, Possovre ML, Vassalli A, Tafti M. Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy. Nat Commun 2020;11:6034. [PMID: 33247179 DOI: 10.1038/s41467-020-19862-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Nirogi R, Benade V, Daripelli S, Subramanian R, Kamuju V, Bhyrapuneni G, Muddana NR, Mekala VR, Petlu S, Jayarajan P, Badange R, Shinde A, Jasti V. Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation. Psychopharmacology (Berl) 2021;238:1495-511. [PMID: 33550481 DOI: 10.1007/s00213-021-05779-x] [Reference Citation Analysis]
57 Dauvilliers Y, Bogan RK, Šonka K, Partinen M, Foldvary-schaefer N, Thorpy MJ. Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. NSS 2022;Volume 14:531-46. [DOI: 10.2147/nss.s279345] [Reference Citation Analysis]
58 Quaedackers L, Overeem S, Pillen S. Two sides of a coin: differential response to COVID-19 distancing measures in children with narcolepsy. J Clin Sleep Med 2021;17:859-62. [PMID: 33295278 DOI: 10.5664/jcsm.9040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Heidbreder A, Dirks C, Ramm M. Therapy for Cataplexy. Curr Treat Options Neurol 2020;22. [DOI: 10.1007/s11940-020-0619-5] [Reference Citation Analysis]
60 Madan R, Pitts J, Patterson MC, Lloyd R, Keating G, Kotagal S. Secondary Narcolepsy in Children. J Child Neurol 2021;36:123-7. [PMID: 32933368 DOI: 10.1177/0883073820954617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Kornum BR, Jennum P. The case for narcolepsy as an autoimmune disease. Expert Review of Clinical Immunology 2020;16:231-3. [DOI: 10.1080/1744666x.2020.1719832] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Rickenbach C, Gericke C. Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases. Front Neurosci 2022;15:806260. [DOI: 10.3389/fnins.2021.806260] [Reference Citation Analysis]
63 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
64 Lizcano F, Arroyave F. Control of Adipose Cell Browning and Its Therapeutic Potential. Metabolites 2020;10:E471. [PMID: 33227979 DOI: 10.3390/metabo10110471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
65 Li S, Yang J. Pitolisant for treating patients with narcolepsy. Expert Review of Clinical Pharmacology 2020;13:79-84. [DOI: 10.1080/17512433.2020.1714435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
66 Dietmann A, Horn MP, Schinkelshoek MS, Fronczek R, Salmen A, Bargiotas P, Lammers GJ, Khatami R, Bassetti CLA. Conventional autoantibodies against brain antigens are not routinely detectable in serum and CSF of narcolepsy type 1 and 2 patients. Sleep Med 2020;75:188-91. [PMID: 32858359 DOI: 10.1016/j.sleep.2020.08.001] [Reference Citation Analysis]
67 Schinkelshoek MS, Fronczek R, Lammers GJ. Update on the Treatment of Idiopathic Hypersomnia. Curr Sleep Medicine Rep 2019;5:207-14. [DOI: 10.1007/s40675-019-00158-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Ingram DG, Jesteadt L, Crisp C, Simon SL. Treatment and care delivery in pediatric narcolepsy: a survey of parents, youth, and sleep physicians. J Clin Sleep Med 2021;17:875-84. [PMID: 33283753 DOI: 10.5664/jcsm.9054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y. Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy. Sleep 2021:zsab200. [PMID: 34358324 DOI: 10.1093/sleep/zsab200] [Reference Citation Analysis]
70 Mogavero MP, Silvani A, DelRosso LM, Salemi M, Ferri R. Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity. Cancers (Basel) 2021;13:2612. [PMID: 34073579 DOI: 10.3390/cancers13112612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Meusel M, Voß J, Krapalis A, Machleidt F, Vonthein R, Hallschmid M, Sayk F. Intranasal orexin A modulates sympathetic vascular tone - a pilot study in healthy male humans. J Neurophysiol 2022. [PMID: 35044844 DOI: 10.1152/jn.00452.2021] [Reference Citation Analysis]
72 Baumann-Vogel H, Schreckenbauer L, Valko PO, Werth E, Baumann CR. Narcolepsy type 2: A rare, yet existing entity. J Sleep Res 2021;30:e13203. [PMID: 32989797 DOI: 10.1111/jsr.13203] [Reference Citation Analysis]
73 Yuan Y, Zhang Y, Cheng Y, Hou Y, Huang Z, Ma J, Li N, Zhan S. Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder. Front Neurol 2022;13:826013. [DOI: 10.3389/fneur.2022.826013] [Reference Citation Analysis]
74 Theard MA. An Examination of History for Promoting Diversity in Neuroscience. Curr Anesthesiol Rep 2021;:1-12. [PMID: 34393663 DOI: 10.1007/s40140-021-00464-3] [Reference Citation Analysis]
75 Wang Z, Zhong Y, Jiang S, Qu W, Huang Z, Chen C. Case Report: Dysfunction of the Paraventricular Hypothalamic Nucleus Area Induces Hypersomnia in Patients. Front Neurosci 2022;16:830474. [DOI: 10.3389/fnins.2022.830474] [Reference Citation Analysis]
76 Overeem S, van Litsenburg RRL, Reading PJ. Sleep disorders and the hypothalamus. Handb Clin Neurol 2021;182:369-85. [PMID: 34266606 DOI: 10.1016/B978-0-12-819973-2.00025-3] [Reference Citation Analysis]
77 Fronczek R, Arnulf I, Baumann CR, Maski K, Pizza F, Trotti LM. To split or to lump? Classifying the central disorders of hypersomnolence. Sleep 2020;43:zsaa044. [PMID: 32193539 DOI: 10.1093/sleep/zsaa044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
78 Fernandez FX, Flygare J, Grandner MA. Narcolepsy and COVID-19: sleeping on an opportunity? J Clin Sleep Med 2020;16:1415. [PMID: 32347205 DOI: 10.5664/jcsm.8520] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 Barateau L, Lopez R, Chenini S, Pesenti C, Rassu AL, Jaussent I, Dauvilliers Y. Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis. Neurology 2020;95:e2755-68. [PMID: 32963102 DOI: 10.1212/WNL.0000000000010737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
80 Rosenthal L, Thorpy MJ, Nevsimalova S, Mayer G, Han F, Dauvilliers Y. 2018 worldwide survey of health-care providers caring for patients with narcolepsy: WSS narcolepsy task force. Sleep Med 2021;82:23-8. [PMID: 33873103 DOI: 10.1016/j.sleep.2021.03.014] [Reference Citation Analysis]
81 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
82 Berntsson SG, Kristoffersson A, Daniilidou M, Dahl N, Ekström C, Semnic R, Markström A, Niemelä V, Partinen M, Hallböök F, Landtblom AM. Aniridia with PAX6 mutations and narcolepsy. J Sleep Res 2020;29:e12982. [PMID: 31943460 DOI: 10.1111/jsr.12982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollmächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ. European guideline and expert statements on the management of narcolepsy in adults and children. Eur J Neurol 2021;28:2815-30. [PMID: 34173695 DOI: 10.1111/ene.14888] [Reference Citation Analysis]
84 Moreno-Estébanez A, Bilbao Villabeitia I, Echeverria Guibert T, Mendibe Bilbao M, Boyero Durán S, Cabral Martínez L, González-Pinto T, Agirre Beitia G, González Eizaguirre A, Rodríguez-Antigüedad A. Positive oligoclonal bands and CSF pleocytosis in narcolepsy type 1: A case report supporting the immune-mediated hypothesis. J Neuroimmunol 2020;339:577111. [PMID: 31756639 DOI: 10.1016/j.jneuroim.2019.577111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Sunwoo J. Narcolepsy, autoimmunity, and influenza A H1N1 vaccination. encephalitis 2021;1:31-5. [DOI: 10.47936/encephalitis.2021.00010] [Reference Citation Analysis]
86 Garau C, Blomeley C, Burdakov D. Orexin neurons and inhibitory Agrp→orexin circuits guide spatial exploration in mice. J Physiol 2020;598:4371-83. [PMID: 32667686 DOI: 10.1113/JP280158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
87 Ollila HM. Narcolepsy type 1: what have we learned from genetics? Sleep 2020;43:zsaa099. [PMID: 32442260 DOI: 10.1093/sleep/zsaa099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
88 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2021. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
89 Williams RH, Tsunematsu T, Thomas AM, Bogyo K, Yamanaka A, Kilduff TS. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy. J Neurosci 2019;39:9435-52. [PMID: 31628177 DOI: 10.1523/JNEUROSCI.0311-19.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
90 Hoffmann A, Ziller M, Spengler D. Focus on Causality in ESC/iPSC-Based Modeling of Psychiatric Disorders. Cells 2020;9:E366. [PMID: 32033412 DOI: 10.3390/cells9020366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
91 Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Concetti C, Burdakov D. Orexin/Hypocretin and MCH Neurons: Cognitive and Motor Roles Beyond Arousal. Front Neurosci 2021;15:639313. [PMID: 33828450 DOI: 10.3389/fnins.2021.639313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
93 Vellieux G, Frija-Masson J, Rouvel-Tallec A, Drouot X, d'Ortho MP. Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nat Sci Sleep 2021;13:1669-73. [PMID: 34594143 DOI: 10.2147/NSS.S311283] [Reference Citation Analysis]
94 Wiendl H, Gross CC, Bauer J, Merkler D, Prat A, Liblau R. Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases. Nat Rev Neurol 2021;17:433-47. [PMID: 34050331 DOI: 10.1038/s41582-021-00496-7] [Reference Citation Analysis]
95 Hopkins K, Mukherjee S, Ponce D, Mangum J, Jacobson LH, Hoyer D. Development of a LC-ESI-MRM method for the absolute quantification of orexin A in the CSF of individual mice. Medicine in Drug Discovery 2021;11:100102. [DOI: 10.1016/j.medidd.2021.100102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Fraser CL, Lueck CJ. Illusions, hallucinations, and visual snow. Handb Clin Neurol 2021;178:311-35. [PMID: 33832684 DOI: 10.1016/B978-0-12-821377-3.00014-3] [Reference Citation Analysis]
97 Peleg-Raibstein D, Burdakov D. Do orexin/hypocretin neurons signal stress or reward? Peptides 2021;145:170629. [PMID: 34416308 DOI: 10.1016/j.peptides.2021.170629] [Reference Citation Analysis]
98 Cipolli C, Pizza F, Bellucci C, Mazzetti M, Tuozzi G, Vandi S, Plazzi G. Dream Generation and Recall in Daytime NREM Sleep of Patients With Narcolepsy Type 1. Front Neurosci 2020;14:608757. [PMID: 33328876 DOI: 10.3389/fnins.2020.608757] [Reference Citation Analysis]
99 Meskill GJ, Kallweit U, Zarycranski D, Caussé C, Finance O, Ligneau X, Davis CW. Pitolisant for the treatment of cataplexy in adults with narcolepsy. Expert Opinion on Orphan Drugs. [DOI: 10.1080/21678707.2021.2022472] [Reference Citation Analysis]
100 Li C, Spruyt K, Zhang C, Zuo Y, Shang S, Dong X, Ouyang H, Zhang J, Han F. Reliability and validity of the Chinese version of Narcolepsy Severity Scale in adult patients with narcolepsy type 1. Sleep Med 2021;81:86-92. [PMID: 33640842 DOI: 10.1016/j.sleep.2021.02.008] [Reference Citation Analysis]
101 Mogavero MP, DelRosso LM, Fanfulla F, Bruni O, Ferri R. Sleep disorders and cancer: State of the art and future perspectives. Sleep Med Rev 2021;56:101409. [PMID: 33333427 DOI: 10.1016/j.smrv.2020.101409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
102 Jacobson LH, Hoyer D. Losing sleep with age. Science 2022;375:816-7. [PMID: 35201892 DOI: 10.1126/science.abo1822] [Reference Citation Analysis]
103 Geng C, Yang Z, Xu P, Zhang H. Vitamin B12 deficiency is associated with narcolepsy. Clin Neurol Neurosurg 2022;212:107097. [PMID: 34942572 DOI: 10.1016/j.clineuro.2021.107097] [Reference Citation Analysis]
104 Lecomte A, Barateau L, Pereira P, Paulin L, Auvinen P, Scheperjans F, Dauvilliers Y. Gut microbiota composition is associated with narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2020;7:e896. [PMID: 33037102 DOI: 10.1212/NXI.0000000000000896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
105 Ingravallo F, Vignatelli L, Pagotto U, Vandi S, Moresco M, Mangiaruga A, Oriolo C, Zenesini C, Pizza F, Plazzi G. Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR). BMC Neurol 2020;20:176. [PMID: 32393279 DOI: 10.1186/s12883-020-01762-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Pavkovic IM, Kothare SV. Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00712-9] [Reference Citation Analysis]
107 Burdakov D, Peleg-raibstein D. The hypothalamus as a primary coordinator of memory updating. Physiology & Behavior 2020;223:112988. [DOI: 10.1016/j.physbeh.2020.112988] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
108 Trotti LM, Saini P, Crosson B, Meltzer CC, Rye DB, Nye JA. Regional brain metabolism differentiates narcolepsy type 1 and idiopathic hypersomnia. Sleep 2021:zsab050. [PMID: 33693888 DOI: 10.1093/sleep/zsab050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Meskill GJ, Davis CW, Zarycranski D, Doliba M, Schwartz JC, Dayno JM. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials. CNS Drugs 2021. [PMID: 34935103 DOI: 10.1007/s40263-021-00886-x] [Reference Citation Analysis]
110 Equihua-Benítez AC, Equihua-Benítez JA, Guzmán-Vásquez K, Prospero-García O, Drucker-Colín R. Orexin cell transplant reduces behavioral arrest severity in narcoleptic mice. Brain Res 2020;1745:146951. [PMID: 32531224 DOI: 10.1016/j.brainres.2020.146951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Pavkovic IM, Kothare SV. Migraine and Sleep in Children: A Bidirectional Relationship. Pediatric Neurology 2020;109:20-7. [DOI: 10.1016/j.pediatrneurol.2019.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
112 Trotti LM. Central Disorders of Hypersomnolence. Continuum (Minneap Minn) 2020;26:890-907. [PMID: 32756227 DOI: 10.1212/CON.0000000000000883] [Reference Citation Analysis]
113 Straat ME, Schinkelshoek MS, Fronczek R, Lammers GJ, Rensen PCN, Boon MR. Role of Brown Adipose Tissue in Adiposity Associated With Narcolepsy Type 1. Front Endocrinol (Lausanne) 2020;11:145. [PMID: 32373062 DOI: 10.3389/fendo.2020.00145] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Parmar A, Murray BJ, Narang I. Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy. Curr Neurol Neurosci Rep 2020;20:38. [PMID: 32651734 DOI: 10.1007/s11910-020-01057-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Barateau L, Lopez R, Chenini S, Rassu A, Scholz S, Lotierzo M, Cristol J, Jaussent I, Dauvilliers Y. Association of CSF orexin-A levels and nocturnal sleep stability in patients with hypersomnolence. Neurology 2020;95:e2900-11. [DOI: 10.1212/wnl.0000000000010743] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
116 Pellitteri G, Dolso P, Valente M, Gigli GL. Orgasmolepsy in Narcolepsy Type 1 Responsive to Pitolisant: A Case Report. Nat Sci Sleep 2020;12:1237-40. [PMID: 33408544 DOI: 10.2147/NSS.S286358] [Reference Citation Analysis]
117 Dietmann A, Wenz E, van der Meer J, Ringli M, Warncke JD, Edwards E, Schmidt MH, Bernasconi CA, Nirkko A, Strub M, Miano S, Manconi M, Acker J, von Manitius S, Baumann CR, Valko PO, Yilmaz B, Brunner AD, Tzovara A, Zhang Z, Largiadèr CR, Tafti M, Latorre D, Sallusto F, Khatami R, Bassetti CLA. The Swiss Primary Hypersomnolence and Narcolepsy Cohort study (SPHYNCS): Study protocol for a prospective, multicentre cohort observational study. J Sleep Res 2021;:e13296. [PMID: 33813771 DOI: 10.1111/jsr.13296] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Freitag TL, Leffler DA. Inside the Mind of a Cereal Killer: New Insights Into the Effect of Celiac Disease on Central Nervous Systems Function. Gastroenterology 2020;158:2043-5. [PMID: 32247693 DOI: 10.1053/j.gastro.2020.03.068] [Reference Citation Analysis]
119 Nigam M, Leu-Semenescu S, Arnulf I. Successful treatment of drug-resistant cataplexy with the anticholinergic drug tropatepine. J Clin Sleep Med 2021;17:849-51. [PMID: 33231168 DOI: 10.5664/jcsm.9030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Truzzi GM, Naufel MF, Tufik S, Coelho FM. Narcolepsy: the impact of aging, hypocretin deficiency, and years of formal education in olfactory function and abdominal obesity. Arq Neuropsiquiatr 2021;79:808-15. [PMID: 34495122 DOI: 10.1590/0004-282X-anp-2020-0352] [Reference Citation Analysis]
121 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Sanford LD, Tang X. Polysomnographic nighttime features of narcolepsy: A systematic review and meta-analysis. Sleep Med Rev 2021;58:101488. [PMID: 33934047 DOI: 10.1016/j.smrv.2021.101488] [Reference Citation Analysis]
122 Santifort KM, Ives EJ, Fenn J, Raimondi F, Lourinho F, Mandigers PJJ, Bergknut N. Suspected acquired narcolepsy in 8 dogs. J Vet Intern Med 2021;35:1448-54. [PMID: 33960533 DOI: 10.1111/jvim.16116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]